Yang Z - Search Results

1

Identification of Potential Predictors of Prognosis and Sorafenib-Associated Survival Benefits in Patients with Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization.

He K, Yang Z, Liu X, Yang Y, Song W, Wang S, Chen Y. He K, et al. Among authors: yang y, yang z. Curr Oncol. 2022 Dec 29;30(1):476-491. doi: 10.3390/curroncol30010038. Curr Oncol. 2022. PMID: 36661687 Free PMC article.

2

Inhibition of neddylation modification by MLN4924 sensitizes hepatocellular carcinoma cells to sorafenib.

Yang Z, Zhang J, Lin X, Wu D, Li G, Zhong C, Fang L, Jiang P, Yin L, Zhang L, Bie P, Xie CM. Yang Z, et al. Oncol Rep. 2019 Jun;41(6):3257-3269. doi: 10.3892/or.2019.7098. Epub 2019 Apr 4. Oncol Rep. 2019. PMID: 31002342 Free PMC article.

3

Prognostic Signature of Hepatocellular Carcinoma and Analysis of Immune Infiltration Based on m6A-Related lncRNAs.

Guo T, He K, Wang Y, Sun J, Chen Y, Yang Z. Guo T, et al. Among authors: yang z. Front Oncol. 2021 Aug 30;11:691372. doi: 10.3389/fonc.2021.691372. eCollection 2021. Front Oncol. 2021. PMID: 34527575 Free PMC article.

4

Tubulin-binding peptide RR-171 derived from human umbilical cord serum displays antitumor activity against hepatocellular carcinoma via inducing apoptosis and activating the NF-kappa B pathway.

Zhu D, Fang C, Yang Z, Ren Y, Yang F, Zheng S, Jiang M, Miao X, Liu D, Chen B, Yao X, Chen Y. Zhu D, et al. Among authors: yang f, yang z. Cell Prolif. 2022 May;55(5):e13241. doi: 10.1111/cpr.13241. Epub 2022 May 3. Cell Prolif. 2022. PMID: 35504605 Free PMC article.

5

A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.

Chen W, Yang Z, Chen Y. Chen W, et al. Among authors: yang z. Dis Markers. 2022 Sep 5;2022:3594901. doi: 10.1155/2022/3594901. eCollection 2022. Dis Markers. 2022. PMID: 36105252 Free PMC article.

6

Development and Validation of a Vascular Endothelial Growth Factor A-associated Prognostic Model for Unresectable Hepatocellular Carcinoma.

He K, Liu X, Yang Z. He K, et al. Among authors: yang z. J Hepatocell Carcinoma. 2023 Feb 5;10:139-156. doi: 10.2147/JHC.S399299. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36777498 Free PMC article.

7

Risk factors analysis of surgical complications of hepatic hemangioma: a modified Clavien-Dindo classification-based study.

Yang K, Ma Y, Yang Z, Yang Y, Song W, Chen W, Lv W, Zhang R, Chen Y, Qiao H. Yang K, et al. Among authors: yang y, yang z. BMC Surg. 2023 May 6;23(1):111. doi: 10.1186/s12893-023-02009-3. BMC Surg. 2023. PMID: 37149572 Free PMC article.

8

A ferroptosis-related ceRNA network in hepatocellular carcinoma for potential clinical applications.

Yang Z, He K, Chen W, Chen Y. Yang Z, et al. Am J Transl Res. 2023 Jun 15;15(6):3912-3927. eCollection 2023. Am J Transl Res. 2023. PMID: 37434825 Free PMC article.

9

CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer.

Yang K, Ma Y, Chen W, Liu L, Yang Z, He C, Zheng N, Liu X, Cheng X, Song J, Chen Y, Qiao H, Zhang R. Yang K, et al. Among authors: yang z. Sci Rep. 2024 Apr 13;14(1):8575. doi: 10.1038/s41598-024-59154-9. Sci Rep. 2024. PMID: 38609450 Free PMC article.

10

The protective role of RACK1 in hepatic ischemia‒reperfusion injury-induced ferroptosis.

Yang Z, Gao W, Yang K, Chen W, Chen Y. Yang Z, et al. Among authors: yang k. Inflamm Res. 2024 Nov;73(11):1961-1979. doi: 10.1007/s00011-024-01944-y. Epub 2024 Sep 18. Inflamm Res. 2024. PMID: 39292271

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,789 results

Search Page

Filters